Transcenta Holding Limited (6628.HK)

HKD 1.25

(2.46%)

Total Debt Summary of Transcenta Holding Limited

Transcenta Holding Limited's latest annual total debt in 2023 was 409.62 Million CNY , down -0.45% from previous year.
Transcenta Holding Limited's latest quarterly total debt in 2024 Q2 was 335.42 Million CNY , up 5.92% from previous quarter.
Transcenta Holding Limited reported annual total debt of 411.46 Million CNY in 2022, up 12.82% from previous year.
Transcenta Holding Limited reported annual total debt of 364.71 Million CNY in 2021, up 43.42% from previous year.
Transcenta Holding Limited reported quarterly total debt of 335.42 Million CNY for 2024 Q2, up 5.92% from previous quarter.
Transcenta Holding Limited reported quarterly total debt of 409.62 Million CNY for 2023 Q4, up 1.17% from previous quarter.

Annual Total Debt Chart of Transcenta Holding Limited (2023 - 2019)

Historical Annual Total Debt of Transcenta Holding Limited (2023 - 2019)

Year	Total Debt	Total Debt Growth
2023	409.62 Million CNY	-0.45%
2022	411.46 Million CNY	12.82%
2021	364.71 Million CNY	43.42%
2020	254.29 Million CNY	-1.88%
2019	259.17 Million CNY	0.0%

Year	Total Debt	Total Debt Growth
2024 Q1	335.42 Million CNY	-18.12%
2024 Q2	335.42 Million CNY	5.92%
2023 Q4	409.62 Million CNY	1.17%
2023 Q1	434.27 Million CNY	5.54%
2023 Q3	404.88 Million CNY	-7.88%
2023 Q2	439.5 Million CNY	1.21%
2023 FY	409.62 Million CNY	-0.45%
2022 FY	411.46 Million CNY	12.82%
2022 Q4	411.46 Million CNY	1.29%
2022 Q3	406.21 Million CNY	-2.16%
2022 Q2	415.19 Million CNY	1.52%
2022 Q1	408.97 Million CNY	14.1%
2021 FY	364.71 Million CNY	43.42%
2021 Q4	358.43 Million CNY	0.0%
2021 Q3	358.43 Million CNY	7.07%
2021 Q2	334.76 Million CNY	23.06%
2021 Q1	272.03 Million CNY	10.23%
2020 Q1	- CNY	0.0%
2020 FY	254.29 Million CNY	-1.88%
2020 Q4	246.79 Million CNY	0.0%
2020 Q3	246.79 Million CNY	0.0%
2019 FY	259.17 Million CNY	0.0%

Peer Total Debt Comparison of Transcenta Holding Limited

Name	Total Debt	Total Debt Difference
Uni-Bio Science Group Limited	52.86 Million HKD	-674.826%
CK Life Sciences Int'l., (Holdings) Inc.	5.93 Billion HKD	93.094%